WHO ICTRP trial
Comparison of Holmium Laser Enucleation of the Prostate (HoLEP) versus MOSESTM…
DRKS00030642 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00030642 |
|---|---|
| Public title | Comparison of Holmium Laser Enucleation of the Prostate (HoLEP) versus MOSESTM Laser Enucleation of the Prostate (MoLEP) in Benign Prostate Syndrome (BPS) - a prospective randomized non-inferiority study |
| Scientific title | Comparison of Holmium Laser Enucleation of the Prostate (HoLEP) versus MOSESTM Laser Enucleation of the Prostate (MoLEP) in Benign Prostate Syndrome (BPS) - a prospective randomized non-inferiority study |
| Primary sponsor | Universitätsklinikum Frankfurt Klinik für Urologie |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Germany |
| Conditions | N40;Hyperplasia of prostate |
| Interventions | Group 1: Patients receive the classic HoLEP as a surgical procedure. Group 2: The patients receive the new MoLEP as a surgical procedure. |
| Registration date | Mar 1, 2023 |
| Target size | 152 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: